Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs55810147 | chr16:85219628 | C/T | 3.67E-9 | 175 | 25.77 | 23.83 | 15 | KM Plot |
PCPG | rs55825845 | chr7:105166713 | A/G | 6.1E-5 | 177 | 20.2 | 28.95 | 2.28 | KM Plot |
PCPG | rs55878652 | chr2:241538061 | T/C | 0.000202 | 178 | 25.92 | 20.17 | 17.27 | KM Plot |
PCPG | rs55880713 | chr21:38503443 | C/T | 1.11E-16 | 174 | 24.7 | 25.63 | 3.17 | KM Plot |
PCPG | rs55885765 | chr2:236194064 | A/C | 2.27E-7 | 175 | 25.97 | 25.05 | 3.07 | KM Plot |
PCPG | rs55892993 | chr10:50525017 | G/A | 3.6E-6 | 176 | 24.52 | 35.5 | 25.17 | KM Plot |
PCPG | rs55893551 | chr2:241528927 | G/A | 3.68E-5 | 177 | 25.97 | 20.2 | 10.3 | KM Plot |
PCPG | rs55906043 | chr7:105165367 | T/G | 5.12E-5 | 178 | 20.2 | 29.43 | 2.28 | KM Plot |
PCPG | rs55918624 | chr2:118694477 | T/C | 1.6E-5 | 178 | 25.17 | 30.93 | 11.65 | KM Plot |
PCPG | rs55922564 | chr7:105155890 | G/A | 5.12E-5 | 178 | 20.2 | 29.43 | 2.28 | KM Plot |
PCPG | rs55949311 | chr13:54131916 | G/T | 0.000227 | 177 | 25.67 | 19.87 | 3.17 | KM Plot |
PCPG | rs55952217 | chr16:89578141 | T/C | 0.000292 | 177 | 26.78 | 25.28 | 19.87 | KM Plot |
PCPG | rs55955356 | chr19:19675087 | T/C | 0.000465 | 178 | 25.67 | 27.2 | 20.25 | KM Plot |
PCPG | rs55967123 | chr7:105163678 | C/A | 5.12E-5 | 178 | 20.2 | 29.43 | 2.28 | KM Plot |
PCPG | rs55976923 | chr2:241528968 | G/C | 3.68E-5 | 177 | 25.97 | 20.2 | 10.3 | KM Plot |